Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Spectranetics Refocuses On CLI Indication After PELA Submission Setback

Jul 21 2003

Related Content

Expanded CVX-300 Claims Are Spectranetics CEO’s First Order Of Business

Jan 27 2003

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window